Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Market Cap	24.41B
Revenue (ttm)	4.37B
Net Income (ttm)	1.19B
Shares Out	919.78M
EPS (ttm)	1.30
PE Ratio	20.41
Forward PE	19.51
Dividend	0.38 (1.42%)
Ex-Dividend Date	May 28, 2024

Volume	16,474,162
Average Volume	14,771,124
Open	24.03
Previous Close	26.83
Day's Range	24.03 - 27.55
52-Week Range	16.62 - 27.55
Beta	0.11
RSI	74.43
Earnings Date	Apr 26, 2025

About SHE:002773

Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs. Chengdu Kanghong Pharmaceuticals Group Co., Ltd. was founded in 1996 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,289
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002773

Financial Performance

In 2023, SHE:002773's revenue was 3.96 billion, an increase of 16.77% compared to the previous year's 3.39 billion. Earnings were 1.04 billion, an increase of 16.52%.